Publications by authors named "Federico Monaco"

Claim this Profile
I
Ionic Conductivity of Composite Polymer Electrolyte: Clarifying the Role of the Interface with Nonconductive Particles.
Guillaume Navallon, Federico Monaco, Katharina Märker, Peter Cloetens, Jakub Drnec

ChemSusChem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trial.
Giulia Benevolo, Daniela Drandi, Nicoletta Villivà, Anna Castiglione, Federico Monaco

Br J Haematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AI and Big Data: Current and Future Nursing Practitioners' Views on Future of Healthcare Education Provision.
Antonio Bonacaro, Ivan Rubbi, Giovanna Artioli, Federico Monaco, Leopoldo Sarli

Stud Health Technol Inform· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells.
Mattia D'Agostino, Delia Rota-Scalabrini, Angelo Belotti, Luca Bertamini, Maddalena Arigoni, Federico Monaco

Blood Cancer J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing satisfaction in simulation among nursing students: psychometric properties of the Satisfaction with Simulation Experience - Italian Version scale.
Sara Alberti, Massimo Guasconi, Marina Bolzoni, Giulia Donnini, Paola Volpi, Federico Monaco

BMC Nurs· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice.
Rita Tavarozzi, Giulia Zacchi, Daniela Pietrasanta, Gioacchino Catania, Alessia Castellino, Federico Monaco

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding chronic pain in the ubiquitous community: the role of open data.
Federico Monaco, Emmanouil Georgiadis, Kakia Chatsiou, Antonio Bonacaro

Front Pain Res (Lausanne)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Bruton's kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib.
Gioacchino Catania, Rita Tavarozzi, Giacomo Maria Pini, Tiziana Borra, Carolina Gandolfo, Federico Monaco

J Basic Clin Physiol Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.
Luca Bertamini, Stefania Oliva, Delia Rota-Scalabrini, Laura Paris, Sonia Morè, Federico Monaco

J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of particle network in composite battery cathodes.
Jizhou Li, Nikhil Sharma, Zhisen Jiang, Yang Yang, Federico Monaco

Science· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.
Laure Vincent, Luuk Gras, Patrice Ceballos, Jürgen Finke, Jakob Passweg, Federico Monaco

Bone Marrow Transplant· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
Roberto Mina, Antonietta Pia Falcone, Sara Bringhen, Anna Marina Liberati, Norbert Pescosta, Federico Monaco

Blood Cancer J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does open data tell us everything?
Leopoldo Sarli, Federico Monaco

Acta Biomed· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma.
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D'Agostino, Massimo Offidani, Federico Monaco

Blood· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study.
Roberto Mina, Angelo Belotti, Maria Teresa Petrucci, Renato Zambello, Andrea Capra, Federico Monaco

Blood Cancer J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
Alessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, Carlo Visco, Monica Tani, Federico Monaco

Oncologist· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience.
Miriam Marangon, Vittorio Stefoni, Alessia Castellino, Carlo Visco, Monica Tani, Federico Monaco

Clin Lymphoma Myeloma Leuk· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms.
Federico Monaco, Bart L Scott, Thomas R Chauncey, Finn B Petersen, Barry E Storer

Haematologica· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. A Commentary of the Pivotal Trial by Raje et al. Published on Lancet Oncology.
Vittorio Fusco, Giuseppina Campisi, Paul de Boissieu, Federico Monaco, Anna Baraldi

Dent J (Basel)· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the .
Sergio Storti, Michele Spina, Emanuela Anna Pesce, Flavia Salvi, Michele Merli, Federico Monaco

Haematologica· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL).
Roberto Mario Santi, Manuela Ceccarelli, Elisa Bernocco, Chiara Monagheddu, Andrea Evangelista, Federico Monaco

Thromb Haemost· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Alessandro Busca, Anna Candoni, Ernesta Audisio, Roberto Passera, Benedetto Bruno, Federico Monaco

Biol Blood Marrow Transplant· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures.
Gioacchino Catania, Federico Monaco, Giulia Limberti, Manuela Alessio, Iolanda De Martino

Dent J (Basel)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online access and motivation of tutors of health professions higher education.
Federico Monaco, Leopoldo Sarli, Massimo Guasconi, Emanuela Alfieri

Acta Biomed· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.
Francesco Zallio, Laura Mazzucco, Federico Monaco, Maria Rosa Astori, Roberto Passera

Biol Blood Marrow Transplant· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis